Contribution of genetical analysis for diagnosis of von Willebrand's disease type 2B

Haemophilia

Volumn 15, Issue 2, 2009, Pages 610-612

  Victor, M ^a   Rugeri, Lucia ^a   Nougier, C ^a   Meunier, S ^a   Fretigny, M ^a   Negrier, C ^a   Vinciguerra, C ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGAROSE; ARGININE; CYSTEINE; DODECYL SULFATE SODIUM; RISTOCETIN;

AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ECCHYMOSIS; ELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EXON; FAMILY HISTORY; FAMILY STUDY; FEMALE; GENETIC ANALYSIS; HUMAN; MALE; MENORRHAGIA; METRORRHAGIA; PARTIAL THROMBOPLASTIN TIME; PEDIGREE ANALYSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA; THROMBOCYTOPENIA; VON WILLEBRAND DISEASE; VON WILLEBRAND DISEASE TYPE 2B;

FAMILY; FEMALE; HUMANS; MALE; PEDIGREE; POINT MUTATION; REFERENCE VALUES; SEQUENCE ANALYSIS, DNA; VDJ EXONS; VON WILLEBRAND DISEASES;

EID: 63349091837     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01966.x     Document Type: Article

References (6)

1. Ruggeri ZM, Pareti FI, Mannucci PM, Ciavarella N, Zimmermann TS. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand disease. N Engl J Med 1980; 302: 1047-51.
2. Hampshire D. ISTH SSC VWF Database. UK: University of Sheffield. Available at: http://www.vwf.group.shef.ac.uk/.
3. Casana P, Martinez F, Haya S, Tavares A, Aznar JA. New mutations in exon 28 of the von Willebrand factor gene detected in patients with different types of von Willebrand's disease. Haematologica 2001; 86: 414-9.
4. Weiss HJ. Sussman II A new von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers. Blood 1986; 68: 149-56.
5. Baronciani L, Federici AB, Castaman G, Punzo M, Mannucci PM. Prevalence of type 2b" Malmö/New York' von Willebrand disease in Italy: the role of von Willebrand factor gene conversion. J Thromb Haemost 2008; 6: 887-90.
6. Holmberg L, Dent JA, Schneppenheim R, Budde U, Ware J, Ruggeri ZM. von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure. J Clin Invest 1993; 91: 2169-77.